Electronic Drug Delivery System Market by Type (Electronic Autoinjectors, Electronic Inhalers, Electronic Injection Pens), Indication (Asthma & COPD, Cardiovascular Disease, Diabetes), Distribution Channel - Global Forecast 2024-2030

Electronic Drug Delivery System Market by Type (Electronic Autoinjectors, Electronic Inhalers, Electronic Injection Pens), Indication (Asthma & COPD, Cardiovascular Disease, Diabetes), Distribution Channel - Global Forecast 2024-2030


The Electronic Drug Delivery System Market size was estimated at USD 11.35 billion in 2023 and expected to reach USD 12.56 billion in 2024, at a CAGR 11.43% to reach USD 24.22 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Electronic Drug Delivery System Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Electronic Drug Delivery System Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Electronic Drug Delivery System Market, highlighting leading vendors and their innovative profiles. These include Amgen, Inc., Astrazeneca PLC, Bayer AG, Becton, Dickinson and Company, Canè SPA, Debiotech S.A., F.Hoffmann-La Roche, Ltd., Findair SP. Z O. O., Insulet Corporation, Medtronic PLC, Merck Group, Novo Nordisk A/S, Tandem Diabetes Care, Inc., United Therapeutics Corporation, and Vicentra B.V..

Market Segmentation & Coverage

This research report categorizes the Electronic Drug Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Electronic Autoinjectors

Electronic Inhalers

Electronic Injection Pens

Electronic Wearable Infusion Pumps
Indication
Asthma & COPD

Cardiovascular Disease

Diabetes

Multiple Sclerosis
Distribution Channel
Hospital Pharmacies

Online Pharmacies

Retail Pharmacies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Electronic Drug Delivery System Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Electronic Drug Delivery System Market?
3. What are the technology trends and regulatory frameworks in the Electronic Drug Delivery System Market?
4. What is the market share of the leading vendors in the Electronic Drug Delivery System Market?
5. Which modes and strategic moves are suitable for entering the Electronic Drug Delivery System Market?PDF E-mail From Publisher (2-5)Users License


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Electronic Drug Delivery System Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of target diseases
5.1.1.2. Favorable reimbursement scenario in major markets
5.1.1.3. Advancements in technologies and designs
5.1.2. Restraints
5.1.2.1. Preference for alternative drug delivery methods and the probability of errors
5.1.3. Opportunities
5.1.3.1. Increasing demand for biologics and Mabs
5.1.3.2. Growth opportunities in emerging markets
5.1.4. Challenges
5.1.4.1. Unfavorable reimbursement structure in developing countries
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Electronic Drug Delivery System Market, by Type
6.1. Introduction
6.2. Electronic Autoinjectors
6.3. Electronic Inhalers
6.4. Electronic Injection Pens
6.5. Electronic Wearable Infusion Pumps
7. Electronic Drug Delivery System Market, by Indication
7.1. Introduction
7.2. Asthma & COPD
7.3. Cardiovascular Disease
7.4. Diabetes
7.5. Multiple Sclerosis
8. Electronic Drug Delivery System Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies
9. Americas Electronic Drug Delivery System Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Electronic Drug Delivery System Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Electronic Drug Delivery System Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Amgen, Inc.
13.1.2. Astrazeneca PLC
13.1.3. Bayer AG
13.1.4. Becton, Dickinson and Company
13.1.5. Canè SPA
13.1.6. Debiotech S.A.
13.1.7. F.Hoffmann-La Roche, Ltd.
13.1.8. Findair SP. Z O. O.
13.1.9. Insulet Corporation
13.1.10. Medtronic PLC
13.1.11. Merck Group
13.1.12. Novo Nordisk A/S
13.1.13. Tandem Diabetes Care, Inc.
13.1.14. United Therapeutics Corporation
13.1.15. Vicentra B.V.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. ELECTRONIC DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
FIGURE 2. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
FIGURE 3. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ELECTRONIC DRUG DELIVERY SYSTEM MARKET DYNAMICS
FIGURE 7. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ELECTRONIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings